Group 1 - The core viewpoint of the article is that Viatris (01873.HK) reported a decline in revenue for the first half of 2025, while net profit showed a slight increase due to strategic optimizations in its business structure [1] Group 2 - For the first half of 2025, the company's revenue was RMB 831.9 million, representing a year-on-year decrease of 15.27% [1] - The net profit for the same period was RMB 148.6 million, which is a year-on-year increase of 3.05% [1] - The basic earnings per share were RMB 0.06 [1] - The increase in net profit and adjusted non-IFRS net profit was primarily due to the continuous positive growth in the CRO business and strategic optimization of the Langhua business structure, which enhanced profitability [1]
维亚生物(01873.HK)上半年净利润1.486亿元 同比增长3.05%